Ulisse Biomed Spa
MIL:UBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
Cresco Labs Inc
OTC:CRLBF
|
US |
|
M
|
MNtech Co Ltd
KOSDAQ:095500
|
KR |
|
Vinci SA
PAR:DG
|
FR |
|
Destiny Pharma PLC
LSE:DEST
|
UK |
|
Societe LDC SA
PAR:LOUP
|
FR |
|
Bonjour Holdings Ltd
HKEX:653
|
HK |
|
R
|
Roadside Real Estate PLC
LSE:ROAD
|
UK |
|
Mindteck (India) Ltd
NSE:MINDTECK
|
IN |
|
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
JP |
|
Europa Metals Ltd
LSE:EUZ
|
AU |
|
Galliford Try Holdings PLC
LSE:GFRD
|
UK |
|
I
|
Inovalis Real Estate Investment Trust
TSX:INO.UN
|
CA |
|
KPR Mill Ltd
BSE:532889
|
IN |
Cash Flow Statement
Cash Flow Statement
Ulisse Biomed Spa
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(5)
|
(6)
|
(5)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
3
|
4
|
3
|
3
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
0
|
0
|
2
|
1
|
(1)
|
(0)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(1)
-206%
|
(1)
+20%
|
(1)
-44%
|
(1)
+35%
|
(2)
-126%
|
(4)
-74%
|
(3)
+26%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
+16%
|
(0)
+72%
|
(0)
+40%
|
(0)
+28%
|
(0)
+72%
|
(0)
-6%
|
(0)
-194%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
6
|
0
|
0
|
0
|
0
|
(0)
|
0
|
1
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Cash from Financing Activities |
6
N/A
|
6
+0%
|
0
-100%
|
0
-32%
|
0
N/A
|
0
N/A
|
2
+478%
|
3
+12%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
5
N/A
|
4
-13%
|
(1)
N/A
|
(2)
-28%
|
(1)
+34%
|
(2)
-67%
|
(1)
+24%
|
(0)
+87%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(1)
N/A
|
(2)
-47%
|
(1)
+40%
|
(2)
-28%
|
(1)
+34%
|
(2)
-107%
|
(4)
-73%
|
(3)
+24%
|
|